Navigation Links
Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
Date:2/5/2008

HOUSTON, Feb. 5 /PRNewswire-FirstCall/ -- Sharps Compliance Corp. (OTC Bulletin Board: SCOM) ("Sharps" or the "Company"), a leading provider of cost-effective disposal solutions for small quantity generators of medical waste, today announced that David P. Tusa, Executive Vice President and Chief Financial Officer, will present at the RedChip Small-Cap Investor Conference at the Four Seasons Resort Scottsdale beginning at approximately 10:10 a.m. MST (12:10 p.m. EST) on Thursday, February 7, 2008.

A live webcast of the presentation, along with presentation materials, will be available on the Company's website at http://www.sharpsinc.com. If you are unable to listen to the live presentation, an archive will be made available at http://www.sharpsinc.com in the Investor Relations section.

The Sharps webcast can be accessed the following ways:

-- The live webcast can be found at http://www.sharpsinc.com.

Participants should go to the website 10 - 15 minutes prior to the

scheduled conference in order to register and download any necessary

audio software.

To listen to the archived call:

-- The archived webcast will be at http://www.sharpsinc.com.

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading provider of cost-effective medical waste disposal solutions for small quantity generators of medical waste. The Company's flagship product, the Sharps Disposal by Mail System(R), is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin (referred to as "sharps"). The Company also offers a number of products specifically designed for the home healthcare market. Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, healthcare, commercial, professional and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting.

As a fully integrated manufacturer providing customer solutions and services, Sharps Compliance's solid business model, with strong margins and significant operating leverage, and early penetration into emerging markets, uniquely positions the company for strong future growth.

More information on Sharps Compliance can be found on its website at: http://www.sharpsinc.com.

For more information contact: -- OR --

David P. Tusa Tammy Swiatek

Executive Vice President, Kei Advisors LLC

Chief Financial Officer investor relations

& Business Development Phone: (716)843-3853

Phone: (713)660-3514 Email: tswiatek@keiadvisors.com

dtusa@sharpsinc.com


'/>"/>
SOURCE Sharps Compliance Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
2. Sharps Compliance Corp. Announces New Senior Vice President of Sales and Marketing
3. Sharps Compliance Corp. Announces First Quarter Fiscal Year 2008 Conference Call and Webcast
4. Adaptis Compliance Officer Earns Advanced Certificate
5. Mitchell Medical and Jopari Solutions Team up to Offer eBilling Compliance Services to Automobile Property & Casualty Insurance Carriers to Meet New Minnesota Requirements
6. Sharon McCudden Named KePRO Director of Business Process Improvement & Compliance
7. Vendormate Storms into 2008 with Major Milestones for Hospital Vendor Compliance
8. CSL Behrings Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance
9. GetWellNetwork Offers Comprehensive Education Package Enabling Hospitals to Meet Compliance Requirements for Patient Education
10. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
11. TraceSecurity Announces Partnership with PHNS Expanding Compliance Services to Hundreds of Healthcare Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: